Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Acute D2 Receptor Blockade Induced Neuronal Network Changes in Human Volunteers

Trial Profile

Acute D2 Receptor Blockade Induced Neuronal Network Changes in Human Volunteers

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 03 May 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Risperidone (Primary)
  • Indications Aggression; Autistic disorder; Bipolar disorders; Dementia; Schizophrenia; Substance-related disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 17 Aug 2016 Status changed from active, no longer recruiting to completed.
    • 28 Mar 2016 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
    • 26 Aug 2015 Planned End Date changed from 1 Jul 2015 to 1 Jul 2016 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top